Please login to the form below

Not currently logged in
Email:
Password:

McCann Health appoints Adriano Botter as global chief digital officer

Botter previously served as digital director for McCann Health Brazil

Healthcare communications network McCann Health has announced the promotion of Adriano Botter (pictured above) to global chief digital officer.

Prior to taking on the new role, Botter was digital director for McCann Health Brazil. As digital director, he developed partnerships with big technology and social media companies to ‘bridge the gap’ between data, creativity and strategy.

He has 14 years of experience in advertising, having worked for various agencies within WPP and IPD, implementing digital projects for local and global brands.

In his new role as chief digital officer, Botter will lead the transformation of McCann Health’s digital offering across the global network.

“The digital revolution is changing how healthcare professionals engage with patients, how medical professional engage with each other, and is empowering individuals in their own healthcare decision making,” said John Cahill, global chief executive officer of McCann Health.

“Adriano’s ability to meld the power of digital with data, strategy and creativity will bring to life our bold vision of the future of McCann Health,” he added.

Botter will report to Cahill and work closely with Sean MacDonald, McCann Worldgroup's chief digital officer.

Article by
Lucy Parsons

15th March 2021

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...